CPSI Announces Participation in Stifel 2023 Cross Sector Insight Conference
MOBILE, Ala.–(BUSINESS WIRE)–CPSI (NASDAQ: CPSI), a healthcare solutions company, today announced that Chris Fowler, President…
Year: 2023
Procaps Group Reports First Quarter 2023 Results
Constant Currency Net Revenues Increased 10% Quarter-over-Quarter in 1Q23, and 22% increase in Adjusted EBITDA,…
AgreeYa Solutions Named Best Place to Work by CEO Insights
Recognition as a Best Place to Work Validates AgreeYa’s Commitment to Employees FOLSOM, Calif.–(BUSINESS WIRE)–#AgreeYa—AgreeYa…
Matahio Energy completes acquisition of onshore assets in New Zealand
TARANAKI, New Zealand, Jun 6, 2023 – (ACN Newswire) – Matahio Energy has completed the…
Q2 Metals Provides Update on 2023 Exploration Campaign
Vancouver, BC, Jun 6, 2023 – (ACN Newswire) – Q2 Metals Corp. (TSXV: QTWO) (OTCQB:…
PGT Innovations Announces 100% Ownership Stake in Eco Enterprises, LLC
NORTH VENICE, Fla.–(BUSINESS WIRE)–PGT Innovations (NYSE: PGTI), a national leader in the premium window, door,…
Antares Capital Expands Coverage into Europe with Appointment of Sheila Brown
Strategic Addition Supports Firm’s Continued Growth Plans Across Liquid Credit and Direct Lending in Europe…
University of Phoenix Honored with 2023 PESC Award for Career-Minded Learning Best Practices
Award highlights university commitment to preparing and supporting working adult learners with career focused programs…
Experienced Biotech Executive and Deal Maker Joins Zephyr AI as Chief Business Officer
TYSONS, Va.–(BUSINESS WIRE)–Zephyr AI, Inc. (“Zephyr AI”), a company building novel transparent AI to address…
Ascendis Pharma Opens Compassionate Use Program for TransCon™ PTH (palopegteriparatide) in Germany
– Compassionate use enables treating physicians in Germany to request access to investigational TransCon PTH…
Ascendis Pharma Opens Compassionate Use Program for TransCon™ PTH (palopegteriparatide) in Germany
– Compassionate use enables treating physicians in Germany to request access to investigational TransCon PTH…
MDxHealth Announces its Extraordinary General Shareholders’ Meeting
NEWS RELEASE – REGULATED INFORMATION JUNE 5, 2023, 5:30 pm ET/ 23:30 CEST…
MDxHealth Announces its Extraordinary General Shareholders’ Meeting
NEWS RELEASE – REGULATED INFORMATION JUNE 5, 2023, 5:30 pm ET/ 23:30 CEST…
Coherus Announces Positive Final Overall Survival Results of JUPITER-02 Phase 3 Trial Evaluating Toripalimab in Nasopharyngeal Carcinoma
JUPITER-02 Final Overall Survival Analysis in Intent-To-Treat Population Presented at ASCO 2023 – Toripalimab plus…
Coherus Announces Positive Final Overall Survival Results of JUPITER-02 Phase 3 Trial Evaluating Toripalimab in Nasopharyngeal Carcinoma
JUPITER-02 Final Overall Survival Analysis in Intent-To-Treat Population Presented at ASCO 2023 – Toripalimab plus…
Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common Stock
SAN DIEGO, June 05, 2023 (GLOBE NEWSWIRE) — Telesis Bio Inc. (NASDAQ: TBIO), a leader…
Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common Stock
SAN DIEGO, June 05, 2023 (GLOBE NEWSWIRE) — Telesis Bio Inc. (NASDAQ: TBIO), a leader…
Motus GI Announces Appointment of Ravit Ram as Chief Financial Officer
Company completes corporate reorganization focused on reducing operating costs while supporting key value creation drivers,…
Motus GI Announces Appointment of Ravit Ram as Chief Financial Officer
Company completes corporate reorganization focused on reducing operating costs while supporting key value creation drivers,…
Cellectis Showcased Preclinical Data at an Oral Presentation and Two Poster Presentations at the 29th International Society for Cell & Gene Therapy (ISCT 2023) Annual Event
Preclinical data on UCART20x22, Cellectis’ first allogeneic dual CAR T-cell product candidate to treat B-NHL,…